| Primary |
| Hiv Infection |
63.0% |
| Acquired Immunodeficiency Syndrome |
6.5% |
| Prophylaxis Against Hiv Infection |
6.5% |
| Antiretroviral Therapy |
5.4% |
| Cytomegalovirus Chorioretinitis |
4.3% |
| Drug Use For Unknown Indication |
4.3% |
| Opportunistic Infection Prophylaxis |
3.3% |
| Product Used For Unknown Indication |
2.2% |
| Prophylaxis |
2.2% |
| Antiviral Treatment |
1.1% |
| Retroperitoneal Cancer |
1.1% |
|
| Eyelid Function Disorder |
6.9% |
| Maternal Drugs Affecting Foetus |
6.9% |
| Meningitis Coccidioides |
6.9% |
| Necrotising Colitis |
6.9% |
| Nephrolithiasis |
6.9% |
| Osteoporosis |
6.9% |
| Rash |
6.9% |
| Stillbirth |
6.9% |
| Uveitis |
6.9% |
| Abortion Spontaneous |
3.4% |
| Acute Promyelocytic Leukaemia |
3.4% |
| Blood Pressure Abnormal |
3.4% |
| Drug Exposure During Pregnancy |
3.4% |
| Eyelid Ptosis |
3.4% |
| Feeding Disorder Neonatal |
3.4% |
| Hydrocele |
3.4% |
| Lipodystrophy Acquired |
3.4% |
| Myocardial Infarction |
3.4% |
| Neurofibromatosis |
3.4% |
| Portal Hypertension |
3.4% |
|
| Secondary |
| Hiv Infection |
72.6% |
| Antiretroviral Therapy |
15.5% |
| Prophylaxis Against Transplant Rejection |
2.6% |
| Drug Exposure During Pregnancy |
1.8% |
| Antiviral Prophylaxis |
1.5% |
| Product Used For Unknown Indication |
1.4% |
| Drug Use For Unknown Indication |
1.0% |
| Prophylaxis Against Hiv Infection |
0.9% |
| Antiviral Treatment |
0.6% |
| Acquired Immunodeficiency Syndrome |
0.4% |
| Acute Hiv Infection |
0.3% |
| Ill-defined Disorder |
0.3% |
| Maternal Exposure During Pregnancy |
0.2% |
| Maternal Exposure Timing Unspecified |
0.2% |
| Progressive Multifocal Leukoencephalopathy |
0.2% |
| Prophylaxis |
0.2% |
| Intracranial Pressure Increased |
0.1% |
| Pneumocystis Jiroveci Pneumonia |
0.1% |
| Tuberculosis |
0.1% |
| Chronic Obstructive Pulmonary Disease |
0.1% |
|
| Progressive External Ophthalmoplegia |
21.8% |
| Maternal Drugs Affecting Foetus |
7.7% |
| Osteonecrosis |
7.1% |
| Drug Exposure During Pregnancy |
5.8% |
| Transplant Rejection |
5.8% |
| Urine Colour Abnormal |
5.8% |
| Premature Baby |
5.1% |
| Drug Resistance |
4.5% |
| Pregnancy |
4.5% |
| Varices Oesophageal |
4.5% |
| Parkinsonism |
3.8% |
| Splenomegaly |
3.8% |
| Osteoporosis |
3.2% |
| Virologic Failure |
3.2% |
| Maternal Exposure During Pregnancy |
2.6% |
| Sickle Cell Anaemia |
2.6% |
| Treatment Failure |
2.6% |
| Cryptorchism |
1.9% |
| Hepatobiliary Disease |
1.9% |
| Ileal Atresia |
1.9% |
|
| Concomitant |
| Hiv Infection |
57.3% |
| Drug Exposure During Pregnancy |
9.8% |
| Convulsion Prophylaxis |
8.1% |
| Acquired Immunodeficiency Syndrome |
4.9% |
| Antiretroviral Therapy |
4.1% |
| Coronary Artery Disease |
2.0% |
| Renal And Pancreas Transplant |
2.0% |
| Gastritis |
1.6% |
| Infection Prophylaxis |
1.6% |
| Diarrhoea |
1.2% |
| Factor Viii Deficiency |
1.2% |
| Non-hodgkin's Lymphoma |
1.2% |
| Prophylaxis Against Hiv Infection |
1.2% |
| Antibiotic Prophylaxis |
0.8% |
| Hepatitis C |
0.8% |
| Aids Related Complication |
0.4% |
| Antiviral Prophylaxis |
0.4% |
| Asthma |
0.4% |
| Cd4 Lymphocytes Decreased |
0.4% |
| Colony Stimulating Factor Prophylaxis |
0.4% |
|
| Pyrexia |
14.3% |
| Fallot's Tetralogy |
10.7% |
| Hepatitis C |
7.1% |
| Hypospadias |
7.1% |
| Umbilical Hernia |
7.1% |
| Activated Partial Thromboplastin Time Prolonged |
3.6% |
| Adrenal Suppression |
3.6% |
| Congenital Hip Deformity |
3.6% |
| Depression |
3.6% |
| Drug Resistance |
3.6% |
| Hallucination |
3.6% |
| Hip Dysplasia |
3.6% |
| Hyperglycaemia |
3.6% |
| Hypoglycaemia |
3.6% |
| Ileal Atresia |
3.6% |
| Maternal Condition Affecting Foetus |
3.6% |
| Nephrotic Syndrome |
3.6% |
| Nervous System Disorder |
3.6% |
| Neutropenic Sepsis |
3.6% |
| Palpitations |
3.6% |
|
